Optogenetic therapy, based on Nobel prize-winning science, involves turning nerve cells on and off using light ...

September 30, 2026, 10:01 to October 7, 2026, 10:01 (JST)This week, progress was made in preparing for U.S. regulatory ...

Former U.S. Open champion Corey Pavin shared that his wife Lisa’s cancer “never went away completely” after he previously ...

Despite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure ...

A new class of medicines offers steadier protection with fewer injections, while gene therapy is beginning to test the promise of a one-time treatment.

Prioritize North America, cell therapy manufacturing and viral vectors; leverage AI, CRISPR, partnerships and scalable production to accelerate commercializationDublin, Oct. 07, 2026 (GLOBE NEWSWIRE) ...

A gene therapy makes surviving retinal ganglion cells light-sensitive, allowing blind patients to detect objects using stimulating goggles.

Researchers have demonstrated that optogenetic gene therapy can partially restore sight in blind individuals, showing promise for future high-resolution vision restoration.

Scientists have taken another important step toward restoring vision in people with certain inherited forms of blindness. In ...

Atsena expects to complete enrollment in the third part of the Lighthouse study next year. (den-belitsky/iStock/ Plus) Atsena Therapeutics has reported evidence of efficacy in a clinical trial of an ...

Catalent is vying for a stronger foothold in next-gen drug development, and it's betting on developer's need for speed. | ...

Outsource biologics R&D to specialized, AI-enabled CROs to cut costs, shorten trial cycles, optimize resources, improve compliance, and accelerate therapies to market.Dublin, Oct. 07, 2026 (GLOBE ...